首页> 外文会议>Society for Biomaterials Annual Meeting and Exposition >Immunogenicity of a Polyinosinic-Polycytidylic Acid (Poly(I:C))-Adjuvanted Microparticle Vaccine for Leishmaniasis
【24h】

Immunogenicity of a Polyinosinic-Polycytidylic Acid (Poly(I:C))-Adjuvanted Microparticle Vaccine for Leishmaniasis

机译:多胞聚环酸的免疫原性(Poly(I:C)) - LeishManiaisis的佐剂微粒疫苗

获取原文

摘要

Results showed that PICL enhanced the T_H1-associated IgG2a and IgG2b titers, and also increased splenocyte IFN-γ production. In comparison to the soluble NH36/PICL group, microparticle formulation significantly increased T_H1-biased cellular immune responses as evidenced by higher frequency of IFNγ-producing cells and higher total secreted IFN-γ. These results indicate a strong potential for the MP/PICL combination as an adjuvant/delivery system for a Leishmania protein vaccine.
机译:结果表明,PICL增强了T_H1相关的IgG2A和IgG2B滴度,也增加了脾细胞IFN-γ产生。与可溶性NH 36 / PICL组相比,微粒制剂显着增加了T_H1偏置的细胞免疫应答,如IFNγ产生细胞的较高频率和更高的IFN-γ所证明。这些结果表明MP / PICL组合作为LeishMania蛋白疫苗的辅助/送给系统的强大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号